Enovis Corporation
44.80
-0.55 (-1.21%)
At close: Jan 14, 2025, 3:59 PM
46.98
4.85%
After-hours Jan 14, 2025, 07:37 PM EST

Enovis Corporation Revenue Breakdown

Quarter Apr 1, 2022Dec 31, 2021Oct 1, 2021Jul 2, 2021Apr 2, 2021Dec 31, 2020Oct 2, 2020Jul 3, 2020Apr 3, 2020Dec 31, 2019Mar 29, 2019Dec 31, 2018Sep 28, 2018Jun 29, 2018Mar 30, 2018Dec 31, 2017Sep 29, 2017Mar 29, 2013
Fabrication Technology Revenue 647.91M 624.22M 605.97M 629.80M 568.13M 518.67M 491.50M 414.37M 525.54M 333.69M 560.38M 0 0 0 260.00K 500.23M 482.20M 522.04M
Fabrication Technology Revenue Growth +3.80% +3.01% -3.78% +10.86% +9.54% +5.53% +18.61% -21.15% +57.49% -40.45% n/a n/a n/a -100.00% -99.95% +3.74% -7.63% n/a
Medical Technology Revenue 375.46M 399.06M 359.92M 356.12M 311.08M 309.45M 314.43M 205.99M 290.82M n/a 123.53M n/a n/a n/a n/a n/a n/a n/a
Medical Technology Revenue Growth -5.91% +10.87% +1.07% +14.48% +0.53% -1.58% +52.64% -29.17% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

Revenue by Geography

Quarter Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016Dec 31, 2015Dec 31, 2014Dec 31, 2013Dec 31, 2012
Foreign Revenue 554.84M 500.34M 2.29B 1.79B 1.86B 2.79B 2.52B 2.65B 2.84B 3.53B 3.37B 3.12B
Foreign Revenue Growth +10.89% -78.15% +28.16% -4.09% -33.19% +10.76% -5.05% -6.70% -19.41% +4.63% +7.87% n/a
United States Revenue 1.15B 1.06B 1.56B 1.28B 1.46B 877.95M 782.20M 995.19M 1.12B 1.10B 836.64M n/a
United States Revenue Growth +8.43% -32.05% +21.84% -12.33% +66.77% +12.24% -21.40% -11.53% +2.46% +31.22% n/a n/a

Operating Expense Breakdown

Quarter Sep 27, 2024Jun 28, 2024Mar 29, 2024Dec 31, 2023Sep 29, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jul 1, 2022Apr 1, 2022Dec 31, 2021Oct 1, 2021Jul 2, 2021Apr 2, 2021Dec 31, 2020Oct 2, 2020Jul 3, 2020Apr 3, 2020Dec 31, 2019Sep 27, 2019Jun 28, 2019Mar 29, 2019Dec 31, 2018Sep 28, 2018Jun 29, 2018Mar 30, 2018Dec 31, 2017Sep 29, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jul 1, 2016Apr 1, 2016Dec 31, 2015Sep 25, 2015Jun 26, 2015Mar 27, 2015
Selling, General, and Administrative Revenue 249.85M 241.41M 255.69M 211.01M 204.25M 207.88M 207.16M 208.59M 182.19M 225.48M 369.39M 351.67M 334.42M 337.56M 305.72M 281.42M 278.06M 235.73M 291.30M 285.86M 290.50M 307.94M 318.14M 218.07M 194.83M 204.78M 200.52M 198.79M 181.84M 208.22M 206.05M 197.80M 199.50M 213.55M 214.39M 232.84M 237.25M 222.63M 213.23M
Selling, General, and Administrative Revenue Growth +3.50% -5.59% +21.17% +3.31% -1.75% +0.35% -0.68% +14.49% -19.20% -38.96% +5.04% +5.16% -0.93% +10.41% +8.64% +1.21% +17.96% -19.08% +1.90% -1.60% -5.66% -3.21% +45.89% +11.93% -4.86% +2.13% +0.87% +9.32% -12.67% +1.06% +4.17% -0.85% -6.58% -0.39% -7.93% -1.86% +6.57% +4.41% n/a
Research and Development Revenue 20.49M 23.48M 23.38M 18.32M 19.90M 18.92M 18.19M 14.72M 15.60M 15.66M 14.84M 27.40M 20.20M 21.30M 19.90M 19.20M 16.80M 14.10M 18.50M 17.00M 16.30M n/a n/a 34.20M n/a n/a n/a n/a n/a n/a n/a 39.30M n/a n/a n/a 41.50M n/a n/a n/a
Research and Development Revenue Growth -12.73% +0.44% +27.61% -7.95% +5.20% +3.99% +23.55% -5.60% -0.40% +5.52% -45.83% +35.64% -5.16% +7.04% +3.65% +14.29% +19.15% -23.78% +8.82% +4.29% n/a n/a -100.00% n/a n/a n/a n/a n/a n/a n/a -100.00% n/a n/a n/a -100.00% n/a n/a n/a n/a